0.5899
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
7.11%
6.073
|
6.5382 | 6.2846 | 8.4625 | 8.1296 |
| Operating Income/Loss |
7.11%
-6.073
|
-6.5382 | -6.2846 | -8.4625 | -8.1296 |
| Nonoperating Income/Loss |
75.28%
0.0273
|
0.1105 | 0.0299 | 0.0967 | 0.2771 |
| Income/Loss From Continuing Operations Before Tax |
5.94%
-6.0457
|
-6.4276 | -6.2547 | -8.3658 | -7.8525 |
| Income Tax Expense/Benefit |
52.58%
0.00795
|
0.00521 | 0.00473 | - | 0.00739 |
| Income/Loss From Continuing Operations After Tax |
5.90%
-6.0536
|
-6.4328 | -6.2595 | -8.3658 | -7.8599 |
|
|
5.90%
-6.0536
|
-6.4328 | -6.2595 | -8.3658 | -7.8599 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2.47%
49.85
|
48.64 | 1.723 | 33.80 | 30.56 |
| Basic Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.15 | -0.25 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):